Weatherford International plc (WFT)
Weatherford International is one of the world’s leading providers of equipment and services used for the drilling, completion and production of oil and natural gas wells. Its operations are conducted in numerous countries and it has service and sales locations in substantially all of the oil and natural gas producing regions in the world. The company’s products and services are divided into the following four principal operating divisions: Drilling and Intervention Services; Completion Systems; Artificial Lift Systems; and Compression Services.
Weatherford International plc (WFT)‘s Financial Overview
Weatherford International plc (WFT) declined -2.99% yesterday to close its trading session at $2.27. The company has 1 year Price Target of $4.87. Weatherford International plc has 52-Week high of $6.86 and 52-Week Low of $2.19. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 15.73 Million shares yesterday. The firm shows the market capitalization of $2.26 Billion.
Weatherford International plc (WFT) reported its last quarterly earnings on 12/30/2017 where the firm reported its Actual EPS of $-0.33/share against the analyst consensus estimate of $-0.21/share. The difference between the actual and expected EPS is $-0.12 a share with a surprise factor of -57.1%.
The firm is trading with SMA20 of -11.66 Percent, SMA50 of SMA50 Percent and SMA200 of -38.89 percent. Weatherford International plc has P/S value of 0.4. Similarly, the company has Return on Assets of -24.5 percent, Return on Equity of -295.8 percent and Return on Investment of -32.8 Percent. The company shows Gross Margin and Operating Margin of 14.2 percent and -37.4 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 2.3 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 29 analysts offering 12-month price forecasts for Weatherford International PLC have a median target of 5.20, with a high estimate of 7.50 and a low estimate of 2.50. The median estimate represents a +129.07% increase from the last price of 2.27.
Rennova Health, Inc. (RNVA)
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company’s solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.
Rennova Health, Inc. (RNVA)’s Financial Outlook
The 1 analysts offering 12-month price forecasts for Rennova Health Inc have a median target of 8,325.00, with a high estimate of 8,325.00 and a low estimate of 8,325.00. The median estimate represents a +91,483,416.48% increase from the last price of 0.01.
According to Zacks Investment Research, Rennova Health, Inc. has a Consensus Recommendation of NA. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined-12.5% and closed its last trading session at $0.01. The company has the market capitalization of $20000. The stock has 52-week high of $28.35 and 52-Week low of $0. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 15.69 Million shares. The company has a total of 1.66 Million shares outstanding.
The company has YTD performance of -71.16 percent. Beta for Rennova Health, Inc. stands at -0.61. The company has Weekly Volatility of 22.58%% and Monthly Volatility of 48.58%.
Rennova Health, Inc. has distance from 20-day Simple Moving Average (SMA20) of -11.46%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of -99.54%.
The Company currently has ROA (Return on Assets) of -301 percent, Return on Equity (ROE) of 128.9 Percent and Return on Investment (ROI) of 1582.9% with Gross margin of 42 percent.